Peucedanocoumarin I exhibits significant anti-inflammatory and antioxidant activities, making it a compound of interest in pharmaceutical research. It has shown potential in inhibiting key inflammatory mediators such as nitric oxide and prostaglandin E2 in cellular models, suggesting possible application in treating chronic inflammatory diseases. Additionally, its ability to scavenge free radicals supports its role in reducing oxidative stress, which is linked to neurodegenerative disorders and aging-related conditions. Preliminary studies also indicate antitumor properties, where it may induce apoptosis in certain cancer cell lines, highlighting its potential in oncology drug development. Due to its natural origin and bioactivity, it is being explored as a lead compound for designing new therapeutic agents.